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2Précis
Contemporary pediatric trabeculectomy technique with mitomycin-C in phakic infants with glaucoma can be
associated with long term IOP control off medications and with satisfactory visual outcomes.
3Abstract
Purpose: To evaluate the long-term effectiveness and safety of mitomycin-C (MMC) augmented
trabeculectomy undertaken within the first two years of life for the surgical management of glaucoma.
Design: Retrospective, consecutive, non-comparative case series.
Participants: All children who underwent MMC augmented trabeculectomy within two years of birth
between May 2002 and November 2012.
Methods: The medical records of 40 consecutive eyes of 26 children who underwent surgery by a
single surgeon were reviewed. Data collected during routine clinical care were analyzed.
Main Outcome Measures: Assessment of clinical outcomes included intraocular pressure (IOP), final
visual acuity, bleb morphology, surgical complications (early and late), postoperative interventions and
further glaucoma surgery performed. Surgical success was defined as 5mmHg ≤ final IOP ≤ 21mmHg, with 
anti-glaucoma medications (qualified success) and without (complete success), stable ocular dimensions
and optic disc cupping, no further glaucoma surgery (including needling) or loss of light perception. Surgical
outcomes were evaluated using Kaplan-Meier life-table analysis.
Results: 40 eyes of 26 children were studied over a mean follow up period of 62.8 months. The
majority of cases (80%) were primary congenital glaucomas following failed goniotomy surgery. Cumulative
probabilities of survival at 1, 5 & 7 years were 78%, 67% and 60% respectively. Of eyes regarded as
successful, 96% (25/26 eyes) had controlled IOP off topical medication, and 44% achieved visual acuity of
20/40 or better. Only one of the 40 eyes developed a cystic avascular bleb with all the other eyes being
non-cystic in nature (diffuse and elevated or flat) at final follow up. Sixty-four percent (9/14 eyes) of cases
regarded as failures ultimately underwent glaucoma drainage device implantation.
Conclusions: Contemporary pediatric trabeculectomy technique augmented with MMC is an effective
procedure in the management of glaucoma within the first two years of life, as shown by the successful
long-term outcomes and low incidence of sight threatening complications. Trabeculectomy, following failed
goniotomy surgery, or as a primary surgical intervention may offer a phakic infant with glaucoma an
excellent opportunity to achieve long-term control of intraocular pressure off medications and be associated
with optimal visual outcomes.
4Introduction1
Childhood glaucoma is an uncommon disorder characterized by elevated intraocular2
pressure (IOP) related damage to the eye that can be caused by a diverse group of3
conditions. The ultimate therapeutic goal in children with glaucoma is to provide a lifetime of4
vision, for which successful control of IOP is crucial. Medical therapy plays an important role5
in controlling IOP but the mainstay of treatment is surgery, which usually needs to be6
repeated1-4. Surgical intervention is often the case for glaucoma presenting in infancy, that is7
within the first two years of life. The surgical procedure of choice is largely determined by the8
type of glaucoma and may be further influenced by factors such as corneal clarity and the9
surgeon’s experience and practice. The outcomes and longevity of surgical interventions10
may have a significant impact upon the future quality of life of both children and their11
families5.12
13
Primary congenital glaucoma (PCG) is the commonest glaucoma in infancy1, 4 for which14
angle surgery (goniotomy or trabeculotomy) is widely regarded as the primary surgical15
intervention of choice6 due to successful reported outcomes7-9. Poorer outcomes from angle16
surgery are usually reported for secondary childhood glaucomas10, 11. Traditionally,17
trabeculectomy was indicated following failed angle surgery. However, trabeculectomy18
surgery in children is especially challenging as it is less successful when compared to19
adults12, 13 because of a vigorous healing response14. This has necessitated the use of20
adjunctive anti-scarring agents such as mitomycin-C (MMC) but at the cost of an increased21
risk of potentially serious complications such as hypotony and bleb related problems. 15-1922
However even with MMC, the literature suggests disappointing outcomes for trabeculectomy23
in infants (especially less than one year of age) when compared to older children15, 16, 18, 2024
and also when compared to glaucoma drainage devices (GDD)21. GDD in children carry a25
significant risk of tube related problems such as tube-cornea touch in up to 26% cases21-2326
and tube migration or extrusion often necessitating the need for further tube related surgery27
5in up to a third of cases3, 21. Consequently, there is no consensus on the optimum surgery28
following failed angle surgery6.29
30
Contemporary trabeculectomy techniques involving fornix-based conjunctival dissection,31
releasable sutures and a wide area of anti-scarring application (a technique often described32
as the Moorfields Safer Surgery System)24, 25 have evolved over the past 15 years with the33
aim of encouraging posterior aqueous flow and the development of diffuse drainage blebs.34
These changes were developed to reduce the high incidence of sight threatening35
complications, particularly bleb related problems, in children and subsequently applied to36
adult surgery. 26, 27 The aim of this study was therefore to evaluate the long-term safety and37
effectiveness of this surgical technique in infants undergoing trabeculectomy within the first38
two years of life.39
40
Patients and Methods41
The protocol for this project was granted institutional review board approval by the Clinical42
Audit Assessment Committee of Moorfields Eye Hospital. A retrospective case note review43
was performed on the records of all children aged two years or younger that underwent44
MMC augmented trabeculectomy by a single surgeon (MP) between May 2002 and45
November 2012. Some children underwent sequential surgery to both eyes but no46
simultaneous bilateral surgery was performed. In these situations, each individual eye was47
regarded as a separate data entity for the purpose of analysis. All cases had a minimum of48
12 months of follow up.49
50
Standard Surgical Technique51
The surgical procedure involved the creation of a superior fornix-based conjunctival peritomy52
and a rectangular (5mm x 4mm) lamellar scleral flap with a crescent blade at the 12 o’ clock53
position. Due to the very elastic nature of the infantile sclera, only short radial cuts were54
6made which enabled tight closure without the need to suture the radial edge of the flap whilst55
also encouraging posterior aqueous flow. A wide area of subconjunctival space56
(approximately 3 clock hours) was then treated with MMC soaked Merocel corneal shields57
(Beaver Visitec, UK), as was the undersurface of the scleral flap with a tear film strip (Sno-58
strips, Chauvin Pharmaceuticals Limited, UK) cut to size. MMC was applied at59
concentrations varying between 0.1-0.5mg/ml (at surgeon’s discretion dependent upon risk60
factors for failure) for 3 minutes before irrigation with 20ml of balanced salt solution. 10-061
nylon (Alcon, UK) was used to preplace intralamellar scleral sutures, with a fixed suture at62
each corner and two releasable sutures at the posterior edge of the scleral flap. Following63
insertion of an anterior chamber (AC) maintainer (Lewicky, Beaver Visitec UK), the AC was64
entered at the anterior edge of the scleral bed. A 500μm sclerostomy was created with a 65
Khaw Descemet membrane punch 7-101 (Duckworth & Kent, UK) followed by a surgical66
iridectomy. Further sutures were placed in the scleral flap, as required, with the aim of67
achieving no aqueous flow through the flap at the end of procedure. Tenonectomy was not68
performed. The conjunctiva was closed with 10-0 nylon sutures and in most cases a small69
volume of viscoelastic (usually Provisc® (Alcon, UK)) and sterile air were injected into the70
AC. Subconjunctival injections of steroid (Betamethasone) and antibiotic (Cefuroxime) were71
given at the end of the case. All eyes were patched overnight.72
73
Postoperatively, all patients received daily intensive steroid drops (dexamethasone 0.1%)74
every 2-3 hours and ointment at night (Maxitrol – dexamethasone, neomycin sulfate and75
polymyxin b sulfate ointment). Topical steroids were gradually weaned over 3-5 months as76
dictated by the degree of conjunctival inflammation. Antibiotic drops (Chloramphenicol) four77
times a day were usually stopped within 2-3 weeks of surgery once all exposed sutures were78
removed. Cycloplegics were not routinely administered. Parents were advised to tape a79
plastic shield over the operated eye at night time for the first month after surgery.80
81
Postoperative Management82
7All children were examined at 1 day, 1 week, three weeks and six weeks after surgery, with83
subsequent outpatient visits dependent upon clinical progress. Examination under Ketamine84
anesthesia (EUA) took place at 1, 3 and 6 weeks after surgery when releasable sutures85
were loosened or removed and subconjunctival steroid and/or 5-fluorouracil (5-FU) injections86
(0.2-0.3ml of 50mg/ml solution) administered depending upon the characteristics of the bleb87
and the degree of bleb inflammation. Measurements of corneal diameter and axial length88
were also performed. Subsequently, additional glaucoma surgery was undertaken in eyes89
uncontrolled by glaucoma medications.90
91
Visual acuity, IOP, slit lamp biomicroscopy examining bleb morphology, anterior chamber92
depth, wound status and lens clarity were routinely performed along with evaluation of the93
optic nerve and retina at each postoperative visit. Quantitative visual acuity was measured94
when the child’s age and developmental abilities allowed. IOP measurements were obtained95
using either Perkins applanation tonometry under Ketamine anesthesia, rebound tonometry96
(Icare, Finland) or Goldmann applanation tonometry as the children became older.97
Amblyopia was appropriately treated with refractive correction and a patching regime.98
99
Outcome Measures100
Surgical success was defined as IOP≤21mmHg and ≥5mmHg either with (qualified success) 101
or without (complete success) topical glaucoma medications, no further glaucoma surgery102
(including bleb needling which was considered a failure), no devastating complications or the103
loss of light perception vision and stable ocular dimensions (axial length, corneal diameter)104
and optic disc cupping. Manipulation of the scleral flap (bleb massage), removal/adjustment105
of releasable sutures were not considered as criteria for failure, as these comprise routine106
post-surgical care with the technique employed. Complications and details of postoperative107
interventions following the initial trabeculectomy were noted.108
109
Statistical Methods110
8Data analysis was performed using Graphpad Prism (Graphpad, USA). Demographic data111
were reported as the mean ± standard error with the range specified. Surgical success was112
evaluated by Kaplan-Meier life-table analysis. Survival curves between subgroups were113
compared using the log-rank (Mantel-Cox) test with Chi-Squared significance test.114
Parameters between the groups designated success and failure were compared using either115
a two-tailed unpaired t-test with Welch’s correction or else by a Mann-Whitney Test,116
depending on whether the populations fitted a Gaussian distribution as shown by the117
D’Agostino & Pearson normality test. Retrospective contingency table analysis was118
performed using a two-tailed Fishers Exact Test. Statistical significance was considered for119
values at p<0.05.120
121
Results122
Patient Demographics and Preoperative Clinical Status123
Forty consecutive eyes of twenty-six children were identified as having undergone MMC124
augmented trabeculectomy before two years of age within the designated study period. The125
full patient record was available for all the cases identified and the baseline demographic126
data of the group studied are summarized in Table 1. Children ranged in age from 1 to 19127
months with a mean of 9.0 ± 0.8 months. All eyes were phakic and most had PCG that had128
undergone previous angle surgery in the form of goniotomy with a mean of 1.1 ± 0.1129
procedures. Three eyes with PCG due to corneal edema and four eyes with secondary130
childhood glaucoma (2, AR anomaly and 2 aniridia) did not have goniotomies. Forty-one131
percent of infants with PCG had goniotomy repeated when the first goniotomy had reduced132
the IOP but to an unsatisfactory level. None of the secondary glaucoma cases had angle133
surgery repeated. The mean preoperative IOP was 24.2 ± 0.7 mmHg using an average of134
2.1 ± 0.2 glaucoma medications, with no children receiving pre-operative acetazolamide.135
The population was predominantly white but 23% were of black descent.136
137
9Surgical Procedure and Follow-up Period138
There was a standard surgical approach in all cases as detailed above, with intraoperative139
MMC administered at a mean concentration of 0.22 ± 0.02 mg/ml (range, 0.1 – 0.5mg/ml).140
Eighty-three percent of cases had either 0.1-0.2 mg/ml concentration of MMC during141
surgery. Higher doses of MMC, ie. 0.5mg/ml, were used in children of Black or Middle142
Eastern descent only. The mean duration of follow up in successful cases was 72.9 ± 5.7143
months (range, 26-129 months) and failure was observed at a mean of 29.0 ± 8.2 months144
(range, 1-90) .145
146
Surgical outcomes147
A summary of the postoperative care and outcomes at the final follow up for groups148
designated as success or failure is shown in Table 2.149
150
Twenty-six of forty eyes (65.0%) were considered successful at the time of last follow up, of151
which 62.5% (25/40 cases) were regarded as a complete success and 2.5% (1/40 cases) a152
qualified success with the use of topical medication. The mean postoperative IOP at the last153
follow up visit for all successful eyes was 11.9 ± 0.7 mmHg with a mean reduction of 48.8%154
± 4.0% from the preoperative baseline. Eyes classed as failures had a mean IOP of 23.4 ±155
1.2 mmHg at the time of failure and achieved a mean final IOP of 14.5 ± 1.0 mmHg with a156
38.4% ± 5.1% reduction from baseline after additional surgery. In addition to the IOP157
reading, glaucoma progression was determined by clinical signs and biometric parameters.158
Nine out of the fourteen failures had releasable sutures removed within the first 6 weeks and159
in seven this was also associated with needling. There was no significant difference160
between the dose of MMC, duration of postoperative topical steroids, the number of EUAs,161
5-fluorouracil (5-FU) or steroid injections administered to those deemed successful and162
those considered failures.163
164
10
Kaplan-Meier life-table analysis (Figure 1) demonstrated a mean cumulative probability of165
success (95% confidence interval) at 6 months and 12 months (1 year) of 0.80 (0.64-0.89)166
and 0.78 (0.61-0.88) respectively. The cumulative probabilities of success at 60 months (5167
years) (modelled on 18 eyes) and at 87 months (7.3 years) (modelled on 9 eyes) after168
surgery were 0.67 (0.49-0.80) and 0.60 (0.38-0.76) respectively. When analyzed according169
to age at surgery, there was a trend towards greater success rates at the end of follow up170
observed in those twelve months or younger (70.4%) compared to of those over twelve171
months of age (53.8%). There was no difference in underlying diagnosis between the two172
groups. Life-table analysis comparing outcomes of cases of primary congenital glaucoma to173
those with secondary childhood glaucoma showed no significant difference in survival174
between these etiologies over the course of follow up (Figure 2).175
176
Data from all eyes (including 14 children with both eyes included in the study) were used for177
analysis. There is potential for introducing bias by analyzing fellow eyes as independent178
entities. In order to address this, we performed Cox Regression allowing for clustering,179
which produced similar results to those found ignoring non independence. Of the 14 children180
who had two eyes included in the study, failure was observed in both eyes in 2 children,181
success was observed in both eyes in 5 children. The remaining children failed in one eye182
but were successful in their fellow eye. A test for symmetry was conducted (p=0.7) indicating183
little evidence of an association (albeit with low power). These observations would suggest184
that our findings are robust to non-independence and justify the inclusion of data from all185
eyes in the analyses presented.186
187
Final visual acuity in all eyes studied was 0.69 ± 0.1 with 34.2% achieving the equivalent of188
20/40 or better, 89.5% seeing 20/200 or better and with no cases of loss of light perception.189
Almost half the children with successful outcomes had visual of acuity of 20/40 or better.190
191
Surgical Complications and Postoperative Interventions192
11
There were no recorded cases of hyphema, flat AC, early or late bleb leak, chronic193
hypotony, endophthalmitis or retinal detachment observed in this series. Choroidal effusions194
in the presence of a shallow AC and low IOP were observed in four cases (10%) with B-scan195
ultrasound routinely performed at one week after surgery. Only one of the cases was with196
the use of MMC 0.5mg/ml. Two cases resolved following intracameral viscoelastic injection,197
one case did not resolve following intracameral viscoelastic injection and underwent re-198
suturing of the scleral flap and the fourth resolved with conservative management. All four199
cases went on to have a successful outcome.200
201
Only one of the 40 eyes developed a cystic avascular bleb with all the other eyes being non-202
cystic in nature (diffuse and elevated or flat). This specific case also suffered blebitis ten203
years after trabeculectomy although it responded well to topical and systemic antibiotic204
treatment alone with no change in IOP control or visual acuity. Diffuse, elevated bleb205
morphology was noted in 63% of eyes (25 eyes) and 35% (14 eyes) had a flat appearance,206
of which 86% (12 eyes) were observed in eyes classes as failures.207
208
The presence of cataract, usually a small posterior subcapsular cataract, was noted in 20%209
(8/40) of all eyes across the study group. The presence of cataract was observed in 11.5%210
(3/26) eyes) in the group deemed to be successful at the end of follow up at a mean of 33.7211
 14.4 months after trabeculectomy surgery. None of these patients required cataract212
surgery as their vision was not thought to have been significantly impacted by the cataract to213
warrant surgery (one case had visual acuity of 0.1 and the other 2 cases were unchanged at214
0.8 and 0.9). The majority of observed cataract formation (5/8 cases), including a single215
case that required surgery, occurred in the failure group at a mean of 56.4  10.5 months216
after trabeculectomy surgery. In these cases, cataract development occurred after further217
glaucoma surgeries in all cases (3 cases of needling followed by Baerveldt tube insertion, 1218
12
case of needling followed by repeat trabeculectomy with MMC 0.5mg/ml adjacent to the219
original, 1 case of needling followed by cyclodiode laser).220
221
Reasons for Failure222
Postoperative interventions across the study group are summarized in Table 3. The fourteen223
eyes that failed all did so because of uncontrolled IOP requiring further intervention. All eyes224
that were considered as failures, were due to bleb needling being performed. These were225
performed at a mean 28.2 ± 7.5 months after trabeculectomy with an average of two226
needlings performed per eye. Needling alone controlled the IOP in only 21.4% (3/14 eyes) of227
cases. Ultimately, after failed needlings (11/14 eyes), eight eyes underwent Baerveldt228
implant insertion, one eye underwent a repeat trabeculectomy with MMC 0.5 mg/ml, one eye229
required cyclodiode laser treatment and one eye underwent cyclodiode laser followed by230
Baerveldt implant insertion. There was a significant association with bleb needling and231
further glaucoma surgery being performed (p<0.0001). However despite this group being232
regarded as failures, they did achieve a mean final IOP of 14.5±1.0 mmHg with a mean 38.4233
± 5.1% reduction of IOP from baseline with no loss of light perception vision, indicating that234
needling procedures and subsequent surgeries were largely successful in the restoration of235
intraocular pressure control.236
237
Discussion238
Trabeculectomy has traditionally been the procedure of choice after failed angle surgery to239
control IOP in children. But in contrast to adults, trabeculectomy surgery in children is240
associated with poorer outcomes12, 13 due to a more aggressive healing response14 and the241
potential challenges of reduced compliance and lack of co-operation with examination.242
Nonetheless, success of MMC trabeculectomy in children has been reported to be 59-95%243
(IOP  21mmHg) with short follow up of 2 years or less15-18, 20, 28 reducing to 55% after 6244
years mean follow up29. All these studies are retrospective which makes comparison difficult245
13
as success is influenced potentially by a number of factors such as: definition of success,246
patient’s age and race, case mix (primary and secondary glaucomas), inclusion of non247
phakic patients, previous surgery, surgical technique, dose and duration of MMC, use of 5-248
FU post operatively and duration of follow up.249
250
In a number of studies, infancy has been shown to be a significant risk factor for failure.251
Reported outcomes of trabeculectomy in infants less than one year of age vary between 15-252
43%15, 16, 18, 20. Beck et al20 reported that being aged less than 1 year at the time of surgery253
was associated with almost a six-fold risk of failure. For infants less than 2 years of age,254
Beck et al21 reported a cumulative success rate of 36% (IOP < 23mmHg with medications) in255
24 eyes at 1 year which dropped to only 19% at 6 years in a group with both primary and256
secondary childhood glaucoma which included aphakic and pseudophakic patients. In a257
larger series, Al Hazmi et al described a success rate of 39% (IOP < 21mmHg without258
topical medications) in 66 eyes (unreported follow up) in a study population mostly of PCG259
patients from the Middle East15.260
261
In comparison, our long-term outcomes of trabeculectomy with MMC for glaucoma262
presenting in infants less than 2 years of age are more encouraging, with a cumulative263
probability of success at one and seven years of 78% and 60% respectively. Almost all264
successful cases (25/26; 96%) were not using topical IOP lowering medications at final265
follow up. In infants less than one year of age, 70% were successful at the end of follow up.266
267
The significant difference in outcomes of our study compared to published reports may268
relate to a number of factors. Our study group was predominantly white, PCG cases and269
included no patients with aphakia /pseudophakia or previous surgery involving the270
conjunctiva, both known to be significant risk factors for trabeculectomy failure13, 20, 30-33.271
The pre-operative IOP in our series was lower than in comparable series which may have272
contributed to improved outcomes. Furthermore surgical technique, namely MMC treatment273
14
under the scleral flap also performed by other authors15, 18 and close post-operative274
management with further subconjunctival 5-FU and steroid may have also played a role. It is275
likely the intensive post-operative bleb management achieved early diffuse posterior276
aqueous flow, which contributed to successful long-term outcomes. Although it could be277
argued that a significant number of EUAs were necessary, this has to be seen within the278
context of overall results and that in successful cases (65%) one operation was all that was279
necessary to achieve glaucoma stability over the duration of follow up. In comparison, Taylor280
and colleagues1 describe children with PCG (117 patients) requiring on average of 4.3  3.8281
(range 0-23) operations over a 20 year observation period to manage their glaucoma.282
283
Trabeculectomy surgery in young children has fallen out of favor not only because of284
reported poor outcomes but also because of the association with significant surgical285
complications including flat anterior chambers (10%), choroidal effusions (22%),286
suprachoroidal hemorrhage, retinal detachments and phthisis18, 20. In particular, thin287
avascular, cystic blebs commonly occurred,16,18 predisposing to bleb related infection such288
as endophthalmitis (5-8%)20, 29,and chronic late, bleb leaks (23%)16. As a consequence,289
contemporary pediatric trabeculectomy techniques have evolved in recent years from those290
used by comparative papers (e.g. limbus-based conjunctival flap and fixed sutures) with the291
aim of reducing the burden of complications.24, 25,27 All cases in this series were performed292
using a standardized technique based on the Moorfields Safer Surgery System 24, 25 aimed at293
achieving posteriorly directed aqueous flow. Specific modifications for pediatric294
trabeculectomies include limited radial cuts to avoid anterior limbal flow and excessive flow295
through the flap, MMC treatment under the scleral flap as well as the subconjunctival tissue296
and the use of an AC maintainer in all cases.297
298
In our study the commonest early complication was choroidal effusion at one week after299
surgery in 10% (4/40 eyes), which is lower than the published literature which ranges from300
15
17-23%.16, 20, 21 Susanna et al.18 reported a 5% rate of choroidal detachment but suspected it301
was higher some eyes with shallow anterior chambers were not fully dilated when examined.302
Our observed rate of cataract development in the cohort with successful outcome (11.5% -303
none requiring surgery) was comparable to the existing literature for the same duration of304
follow up21.305
306
The accepted alternative to trabeculectomy following failed angle surgery is the insertion of a307
glaucoma drainage device (GDD). Only a few studies specifically evaluate the performance308
of GDD in the infant population. Success rates at one year are reported at 74-87%21, 34 with309
53% survival at 6 years after surgery21. Our trabeculectomy outcomes are comparable310
although direct comparison is difficult due to the presence of aphakic glaucoma cases in311
these populations. However the major difference between our findings and those reported312
following tube surgery is the significant associated complications often requiring surgical313
revision. Beck et al reported 45.7% of eyes with a GDD required one or more operations due314
to a complication related to the implant (most commonly tube corneal touch and exposure),315
in contrast to 12.5% of eyes in trabeculectomy group21. Tube malposition, erosion and316
endophthalmitis are consistently reported with greater frequency in the pediatric compared317
to adult population 3. Tube malposition requiring further surgery has been reported in 26-318
35% of cases21, 34. These studies also reported corneal decompensation (9%), vitreous319
hemorrhage (7%), endophthalmitis (7%) and retinal detachment (7%) following GDD320
surgery. Overall, complications in our series were fewer than reported in comparable321
literature following trabeculectomy and glaucoma drainage device surgery. This is important322
as the technique is simple and does not require expensive special equipment. Furthermore323
of significance, the need for medications appears to be higher following GDD compared to324
trabeculectomy.20 In one study, only 14% of infants undergoing GDD surgery achieved IOP325
control without topical medications34 compared to 62.5% (25/40) of our trabeculectomy326
cases.327
328
16
Criteria for success in glaucoma are largely based on IOP related parameters and the329
absence of serious complications. However, the preservation of visual function is the goal in330
these children and is influenced by factors other than IOP, such as corneal clarity, refractive331
status and amblyopia which must also be addressed. In our study, final overall visual acuity332
outcomes of 34.2% seeing 20/40 or better, 89.5% seeing 20/200 or better and no cases of333
loss of light perception were very encouraging and comparable to other published reports.35334
335
This study is limited by the retrospective nature of the analysis and with the study population336
comprising predominantly cases of primary congenital glaucoma. A randomized, multicentre337
trial comparing MMC trabeculectomy and GDD would be of interest, as would a study on the338
optimal MMC application method, concentration and duration.339
340
In conclusion, this study demonstrates that MMC augmented trabeculectomy using simple341
contemporary trabeculectomy techniques is an effective option in the management of342
glaucoma within the first two years of life, as shown by the successful long-term outcomes343
and low incidence of sight threatening complications. After failed goniotomy surgery or as344
primary surgery for phakic secondary childhood glaucoma cases, trabeculectomy may offer345
an infant with glaucoma an excellent opportunity to achieve long-term control of intraocular346
pressure off medications and optimal visual outcomes. The close post-operative monitoring347
and need for regular EUA required to achieve these results in comparison to GDD surgery is348
balanced by the significantly lower surgical re-intervention rate and dependence on349
medication for IOP control. Should failure occur later in life, the opportunity for GDD still350
exists and the potential complications of such surgery will be delayed, perhaps beyond the351
more critical period of visual maturation.352
353
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Table 1. Baseline Demographic Information
Patients 26
Eyes 40
Age (range (mean ± SE)) 1 – 19 months (9.0 ± 0.8 months)
Number of previous goniotomies (mean, SE) 1.1 ± 0.1
Diagnosis (n, %)
Primary Congenital Glaucoma 32 (80%)
Axenfeld-Rieger Anomaly 4 (10%)
Aniridia 2 (5%)
Naevus of Ota 1 (2.5%)
Cutis Marmorata Telangectasia 1 (2.5%)
Ethnicity/Race (n, %)
White 26 (65%)
Black 9 (22.5%)
Asian 3 (7.5%)
Middle Eastern 1 (2.5%)
Mixed 1 (2.5%)
Number of topical pre-operative medications
(mean, SE)
2.1 ± 0.2
Pre-operative IOP (mean, SE) 24.2mmHg ± 0.7
SE= standard error
IOP= intraocular pressure
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Table 2. Summary of Final Follow up
Total Success Failure
Eyes 40 26 (65%) 14 (35%)
Time to final follow up
(months)
62.8 ± 5.7
(Range 1-129)
72.9 ± 5.7
(Range 26-129)
29.0 ± 8.2 (†***)
(Range 1-90)
Mean concentration of MMC
(mg/ml)
0.22 (range 0.1-
0.5)
0.22 (range 0.1-
0.5)
0.23 (range 0.1-
0.5)
Number of EUAs 3.6 ± 0.2 3.5 ±0.2 3.9 ± 0.3
Number of Needlings 0.7 ± 0.2 0 1.9 ± 0.2(†**)
Releasable Sutures
Removed/Adjusted
11/40 (27.5%) 2/26 (7.7%) 9/14 (64.3%)
Number of Steroid Injections 2.0 ± 0.2 1.8 ± 0.2 2.5 ± 0.4
Number of 5-FU injections 2.1 ± 0.2 1.8 ± 0.2 2.6 ± 0.4
Duration of postoperative
topical steroids (months)
3.2 ± 0.3 3.1 ± 0.3 3.4 ± 0.5
IOP at Failure (mmHg) 23.4 ± 1.2
Final IOP (mmHg) 12.8 ± 0.6 11.9 ± 0.7 14.5 ± 1.0 (‡*)
Mean % IOP Reduction
from Baseline
45.2% ± 3.2 48.8% ± 4.0 38.4% ± 5.1(†*)
Final VA (logMAR)
20/40 or better
20/200 or better
0.69 ± 0.1
34.2% (13/38)
89.5% (34/38)
0.41 ± 0.1
44.0% (11/25)
92.0% (23/25)
1.2 ± 0.3 (†**)
15.4% (2/13)
69.2% (9/13)
456
Data shown as mean ± standard error457
458
Table 2. Summary of data at final follow up denoting observations of the total sample (40459
eyes), eyes classified as having successful outcomes and eyes classified as failure. The460
populations of successful eyes and those classified a failure were tested for normality using461
the D’Agostino & Pearson normality test and compared with a two-tailed unpaired t-test with462
Welch’s correction (‡) if normality was shown else with a Mann-Whitney test (†). Observed463
significant differences are indicated in the table (*** p<0.0004; ** p<0.0032; * p<0.04).464
(EUA = Examination under anesthesia; 5-FU = 5-Fluorouracil; MMC = Mitomycin-C; VA =465
visual acuity; IOP = intraocular pressure)466
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Table 3. Summary of postoperative procedures performed across all eyes during the follow473
up period. A single case of early hypotony unresponsive to an anterior chamber injection of474
viscoelastic required scleral flap re-suture and went on to be a success.475
476
477
478
Table 3. Post-operative Surgical Interventions
Scleral flap resuture 1/40 (2.5%)
Bleb needling 12/40 (30.0%)
Repeat Trabeculectomy 1/40 (2.5%)
Cyclodiode Laser 2/40 (5.0%)
Aqueous Shunt Insertion 9/40 (22.5%)
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480
Figure 1. Cumulative surgical success after Mitomycin augmented trabeculectomy in infants481
by Kaplan-Meier life-table analysis. Plotted is the probability of success vs follow-up time482
(error bars represent the 95% confidence interval). Mean cumulative probabilities of success483
(95% confidence interval) at 6 months and 12 months (1 year) were 0.80 (0.64-0.89) and484
0.78 (0.61– 0.88) respectively. The cumulative probabilities of success at 60 months (5485
years) and at 87 months (7.3 years) after surgery were 0.67 (0.49–0.80) and 0.60 (0.38–486
0.76) respectively.487
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Figure 2. Cumulative surgical success by etiology after Mitomycin augmented491
trabeculectomy in infants by Kaplan-Meier life-table analysis. Plotted is the probability of492
success vs follow-up time for primary congenital glaucoma (solid line) and secondary493
glaucomas (dotted line). The two curves were not significantly different when compared494
using the log-rank (Mantel-Cox) test.495
496
497
